Opioid dependence with opioid-induced mood disorder
ICD-10 F11.24 is a billable code used to indicate a diagnosis of opioid dependence with opioid-induced mood disorder.
Opioid dependence with opioid-induced mood disorder is characterized by a problematic pattern of opioid use leading to clinically significant impairment or distress. This condition arises when an individual develops a tolerance to opioids, experiences withdrawal symptoms, and continues to use opioids despite adverse consequences. The mood disorder component indicates that the opioid use has led to significant mood disturbances, such as depression or anxiety, which are directly attributable to the substance use. Clinically, patients may present with symptoms like persistent sadness, irritability, or anhedonia, which can complicate the treatment of their opioid dependence. Effective management often requires a multidisciplinary approach, including pharmacotherapy (such as methadone or buprenorphine), psychotherapy, and support groups. The interplay between opioid dependence and mood disorders necessitates careful monitoring and tailored treatment strategies to address both the substance use and the mood disorder effectively.
Comprehensive assessment of substance use history, mood symptoms, and treatment response.
Patients presenting with opioid use disorder and co-occurring depression or anxiety.
Documentation must clearly outline the relationship between opioid use and mood symptoms.
Detailed psychiatric evaluation including mood disorder assessment and substance use history.
Patients with a history of opioid use presenting with depressive symptoms.
Consideration of medication interactions and the impact of opioid use on mood stabilization.
Used in conjunction with F11.24 for comprehensive treatment.
Document the nature of counseling and its relation to opioid dependence and mood disorder.
Addiction specialists should ensure that counseling sessions are tailored to address both substance use and mood symptoms.
Coding F11.24 is crucial for accurately representing the complexity of a patient's condition, which includes both opioid dependence and mood disorder. This specificity helps in tailoring treatment plans and ensuring appropriate reimbursement for services rendered.
